Colchicine clinical trials
Also written Colcrys and Lodoco.
How each study uses Colchicine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Colchicine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 27 Jul 1961 · COLBENEMID · NDA 012383 (FDA, Drugs@FDA; in a combination)
- European Union
- 24 Jul 2026 · Colchicine Agepha Pharma · EMEA/H/C/006653 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
235 studies that test it; most in 2020 (26); 3 more planned to start later
| Year | Studies |
|---|---|
| 1990 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 8 |
| 2008 | 10 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 9 |
| 2014 | 10 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 26 |
| 2021 | 24 |
| 2022 | 22 |
| 2023 | 16 |
| 2024 | 19 |
| 2025 | 19 |
| 2026 | 20 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 27 · Other 212
Mutual Pharmaceutical Company, Inc. (19) · Population Health Research Institute (8) · Ain Shams University (5) · Montreal Heart Institute (5) · Assistance Publique - Hôpitaux de Paris (5) · NYU Langone Health (4) · Azienda Sanitaria Locale 3, Torino (4) · University of Sao Paulo General Hospital (3)
Often tested with
Tested in the same studies.
Rosuvastatin (4) · Aspirin (4) · Rivaroxaban (2) · Methotrexate (2) · Atorvastatin (2) · Febuxostat (2) · Naproxen (2) · Theophylline (2)
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic agents source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 23, 8 in phase 3
Studies that test Colchicine, phase 3 first.
- Dec 2026Colchicine and Inflammation in Aortic StenosisPhase 3 · Radboud University Medical Center
- Mar 2027Colchicine After Electrocardioversion for Atrial FibrillationPhase 3 · University Hospital, Basel, Switzerland
- Mar 2027Colchicine Use for Primary Prevention of Coronary Artery DiseasePhase 3 · Qingdao Central Hospital
- Jun 2027Design and Rationale of the COLT StudyPhase 3 · Azienda Sanitaria Locale ASL 6, Livorno
- Jun 2027Efficacy and Safety of Colchicine After PCIPhase 3 · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Jul 2027Colchicine for Autoimmune and Subacute ThyroiditisPhase 2/3 · Mansoura University
- Sep 2027Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to AtherosclerosisPhase 3 · Assistance Publique - Hôpitaux de Paris
- Nov 2027Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary InterventionPhase 3 · AZ Sint-Jan AV
- Dec 2026The Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade InflammationPhase 2 · Asger Lund, MD
- Dec 2026Colchicine's Effect on Inflammatory MarkersPhase 4 · Ayesha Ather
Studies
Open first, then newest update. How each study uses Colchicine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 239
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutRecruitingPhase 4Massachusetts General HospitalNCT04875702Written as Colchicine 0.6 mg
- Colchicine for the Prevention of Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled TrialEnrolling by invitationPhase 2/3National Taiwan University HospitalNCT07611019Written as Colchicine 0.5 MG oral tablet twice daily
- CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With ColchicineRecruitingPhase 3Niguarda HospitalNCT06158698Written as Colchicine
- AIM2-NLRP3 Inflammasome Dual Inhibitor on hsCRPNot yet recruitingNot applicableUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNCT07933757Written as Colchicine
- Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection FractionRecruitingPhase 2Montreal Heart InstituteNCT06217120Written as Colchicine
- PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosisRecruitingPhase 3Duke UniversityNCT07232069Written as Colchicine 0.5 MG Oral Tablet Once Daily
- Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)Not yet recruitingNot applicableSir Run Run Shaw HospitalNCT07920133Written as Colchicine (Colcrys®)
- REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label TrialNot yet recruitingPhase 2University of Texas Southwestern Medical CenterNCT07654231Written as Low-dose Colchicine at 0.5mg daily
- Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic StrokeNot yet recruitingPhase 4Brazilian Clinical Research InstituteNCT06396858Written as Colchicine 0.5 MG
- Colchicine in Pulmonary Artery Hypertension PatientsNot yet recruitingPhase 2Ain Shams UniversityNCT07907757Written as Colchicine 0.5 MG Oral Tablet
- Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve ReplacementRecruitingNot applicableChina National Center for Cardiovascular DiseasesNCT07411768Written as Colchicine
- Randomized Interventional Clinical Trial on the Prevention of Atrial Fibrillation Using Colchicine, Amiodarone And a Posterior Pericardiotomy.Not yet recruitingPhase 3ElsanNCT07887022Written as Colchicine
- A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After RadiotherapyNot yet recruitingPhase 2M.D. Anderson Cancer CenterNCT07856719Written as Colchicine
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskRecruitingPhase 3Population Health Research InstituteNCT04774159Written as Colchicine 0.5 MG Oral Tablet
- Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal HematopoiesisRecruitingPhase 4Shenyang Northern HospitalNCT07362966Written as Colchicine 0.5 mg orally once daily for 12 months.
- Colchicine for Primary Prevention of Cardiovascular Disease in Adults With Type 2 DiabetesRecruitingPhase 2Tan Tock Seng HospitalNCT07837934Written as Colchicine 0.5 MG Oral Tablet Once Daily
- Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in on Effective CPPD Disease TreatmentRecruitingPhase 2Brigham and Women's HospitalNCT06855433Written as Colchicine Pill
- Colchicine Effect on Amyotrophic Lateral Sclerosis PatientsNot yet recruitingPhase 2Azienda Ospedaliero-Universitaria di ModenaNCT07813858Written as Colchicine 0.5 MG Oral Tablet
- Perioperative Colchicine for TKANot yet recruitingPhase 4Geisinger ClinicNCT06936709Written as Colchicine 1.8 mg + 0.6 mg
- Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral HemorrhageNot yet recruitingPhase 3Population Health Research InstituteNCT06587737Written as Colchicine 0.5 MG
See all 239 studies that test Colchicine →
Given beside what is tested · 13 — Colchicine is usual care or a partner of the new treatment
- COLchicine and Non-enteric Coated Aspirin in the Cardiovascular Outcomes Trial of Patients With Type 2 DiabetesRecruitingPhase 3Montreal Heart InstituteNCT05633810Written as Colchicine
- The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution TimeNot yet recruitingPhase 4First Affiliated Hospital of Wenzhou Medical UniversityNCT07661030Written as colchicine
- Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With GoutCompletedPhase 2Gilead SciencesNCT01336686Written as Colchicine
- Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With GoutCompletedPhase 2Gilead SciencesNCT02252835Written as Colchicine
- Topical Pentoxifylline Gel on Behcet's Disease Oral UlcersCompletedPhase 2Ipekyolu Ilac Ltd. StiNCT03888846Written as Colchicine
- Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS)CompletedPhase 2Dyve Biosciences, Inc.NCT04130204Written as Colchicine 0.6 mg
- A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal ImpairmentTerminatedPhase 4Ironwood Pharmaceuticals, Inc.NCT03226899Written as colchicine
- Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With GoutCompletedPhase 4Menarini International Operations Luxembourg SANCT02500641Written as Colchicine
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With GoutCompletedPhase 3TakedaNCT02139046Written as Colchicine
- Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal ImpairmentCompletedPhase 2TakedaNCT02128490Written as Colchicine
- Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout PatientsCompletedPhase 2Gilead SciencesNCT01399008Written as Colchicine
- Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout PatientsCompletedPhase 2Gilead SciencesNCT01416402Written as Colchicine
- Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate LevelsCompletedPhase 4Tongji HospitalNCT02060552Written as Colchicine
As the comparator · 14 — what is tested is compared with Colchicine
- A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering TreatmentNot yet recruitingPhase 2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.NCT07708181Written as Colchicine 0.5 mg
- Efficacy and Safety of Thalidomide for Pediatric PFAPA SyndromeNot yet recruitingNot applicableWenjie ZhengNCT07476625Written as Colchicine
- PET Imaging of Inflammation and Lipid Lowering StudyCompletedNot applicableUniversity of CambridgeNCT04073797Written as Colchicine
- Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlareCompletedPhase 2Atom Therapeutics Co., LtdNCT07145229Written as Colchicine
- Prednisolone Versus Colchicine for Acute Gout in Primary CareTerminatedPhase 4University Medicine GreifswaldNCT05698680Written as Colchicine 0.5 mg Oral Tablet
- A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)CompletedPhase 2Changchun GeneScience Pharmaceutical Co., Ltd.NCT05936281Written as Colchicine
- Safety and Efficacy of Genakumab for Injection in Patients With Gout FlareCompletedPhase 2Changchun GeneScience Pharmaceutical Co., Ltd.NCT05936268Written as Colchicine
- A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.Active, not recruitingPhase 2Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.NCT06270225Written as Colchicine 0.5 mg
- Effect of Combined Use of Ivermectin and Colchicine in COVID-19 PatientsCompletedPhase 4Ain Shams UniversityNCT05246072Written as Ivermectin + colchicine
- Impact of Colchicine in Hospitalized Colombian Patients With COVID-19TerminatedPhase 3Fundación Universitaria de Ciencias de la SaludNCT04539873Written as Colchicine 0.5 MG
- The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients.CompletedPhase 3Estudios Clínicos Latino AméricaNCT04328480Written as Colchicine
- Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout PatientsCompletedPhase 2Gilead SciencesNCT02063997Written as Colchicine 0.6 mg
- Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe GoutCompletedPhase 2Revive Therapeutics, Ltd.NCT02330796Written as Colchicine
- Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced FibrosisTerminatedPhase 2Hospital Universitario Ramon y CajalNCT00840489Written as Colchicine
What changed recently
From the registry's own updates since Oct 20, 2026.
Started recruiting2
- Reversing Microvascular Dysfunction in Heart Failure With Preserved Ejection FractionNov 10, 2026NCT06217120
- Low-dose Colchicine for Thromboprophylaxis After Transcatheter Aortic Valve ReplacementOct 27, 2026NCT07411768
Stopped2
- Anti-Inflammatory Treatment of Uremic Cardiomyopathy With ColchicineTerminatedNov 18, 2026NCT04500665
- Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA VasculitisTerminatedNov 6, 2026NCT04008316
Newly registered4
- AIM2-NLRP3 Inflammasome Dual Inhibitor on hsCRPNov 12, 2026NCT07933757
- Hs-CRP-Guided Colchicine Treatment Targets in Very-High-Risk Patients With Coronary Artery Disease After PCI (TARGET-CHD)Nov 5, 2026NCT07920133
- Colchicine in Pulmonary Artery Hypertension PatientsOct 30, 2026NCT07907757
- Randomized Interventional Clinical Trial on the Prevention of Atrial Fibrillation Using Colchicine, Amiodarone And a Posterior Pericardiotomy.Oct 21, 2026NCT07887022
Codes
What other systems call Colchicine · ClinicalTrials.gg INT007249
- MeSH (NLM) D003078ColchicineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) SML2Y3J35TCOLCHICINEConfirmed FDA, NLM, Wikidata
- RxNorm 2683Confirmed FDA, Wikidata
- Wikidata Q326224(S)-(−)-colchicineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C385ColchicineOne source FDA
- DrugBank DB01394One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D003078 | Colchicine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | SML2Y3J35T | COLCHICINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2683 | — | Confirmed FDA, Wikidata |
| Wikidata | Q326224 | (S)-(−)-colchicine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C385 | Colchicine | One source FDA |
| DrugBank | DB01394 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.